Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 21 Rectal Neoplasms 18 Colonic Neoplasms 18 Stomach Neoplasms 13 Ovarian Neoplasms 10 Neoplasms 5 Gastrointestinal Stromal Tumors 5 Carcinoma, Hepatocellular 5 Peritoneal Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Prostatic Neoplasms 2 Neoplastic Cells, Circulating 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Venous Thrombosis 1 Uterine Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Robotic 1 Polycystic Ovary Syndrome 1 Pancreatic Neuroendocrine Tumors 1

Interventions

Misoprostol 6 Uterine Myomectomy 4 relugolix 3 Tranexamic Acid 3 Saline Solution 3 Hysterectomy 3 dienogest 2 carbetocin 2 Uterine Artery Embolization 2 Tourniquets 2 Tablets 2 Lidocaine 2 Leuprolide 2 Hysteroscopy 2 Ascorbic Acid 2 ulipristal 1 telapristone acetate 1 remimazolam 1 ramosetron 1 pirfenidone 1 estradiol, norethindrone drug combination 1 Vasopressins 1 Triptorelin Pamoate 1 Tranylcypromine 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myofibroma × Laparoscopy × Clear all

NCT06067971 2025-09-12

ENDORA2

University Hospital, Clermont-Ferrand

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡